Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery
NCT ID: NCT01597427
Last Updated: 2012-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
29 participants
INTERVENTIONAL
2009-03-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure
NCT01297335
Norepinephrine and Phenylephrine, Which Better for Elderly?
NCT04067817
Clonidine and Left Ventricular Dysfunction
NCT00213902
Effect of Phenylephrine Versus Norepinephrine on Venous Return
NCT03872570
The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients
NCT00356226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clonidine
Administration of 2 μg/kg of intravenous clonidine.
Clonidine
Administration of 2 μg/kg of intravenous clonidine
Placebo
Injection of placebo solution.
Placebo
Injection of placebo solution.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clonidine
Administration of 2 μg/kg of intravenous clonidine
Placebo
Injection of placebo solution.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 to 80 years
* Pulmonary hypertension due to left heart disease,
* Physical status 2 or 3 according to the classification system of the American Society of Anesthesiologists,
* Subjected to cardiac circulation with extracorporeal circulation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luiz Fernando dos Reis Falcao
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luiz Fernando R Falcao, Ph.D.
Role: STUDY_CHAIR
Federal University of São Paulo
Benedito B Joao, MD
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Luiz Fernando dos Reis Falcao
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNIFESP-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.